MedPath

Outcomes of High-volume Saline Irrigation VS Povidone-Iodine Solution Cleaning of IOWI in Preventing SSIs in Emergency Laparotomies

Phase 2
Recruiting
Conditions
Surgical Site Infection
Surgical Incision
Laparotomies
Post Operative Wound Infection
Seroma
Surgical Wound
Wound Infection
Emergency Laparotomies
Registration Number
NCT05989386
Lead Sponsor
Dow University of Health Sciences
Brief Summary

The goal of this clinical trial is to compare the outcomes of High-volume saline irrigation vs Povidone-iodine solution cleaning of the intraoperative incision wound in preventing superficial surgical site infections in patients undergoing emergency laparotomies. The main question it aims to answer are:

* Incidence of SSI after intervention

* Length of hospital stay

Participants will be randomly assigned to two groups receiving either of the two groups:

Group A: 1000ml of IOWI with saline solution prior to incision closure Group B: The incisional wound will be closed conventionally without irrigation.

Researchers will compare groups A( experimental group) and B (control group) to compare the incidence of superficial surgical site infections after intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria
  • • Patients undergoing emergency laparotomy under the care of surgical-6 unit of Dr. Ruth K. M. Pfau Civil Hospital Karachi

    • The age of patients should be between 18-60 years old.
Exclusion Criteria
  • Diabetic patients
  • Immune-suppressed patients
  • Patients taking steroids
  • Patients undergoing chemo-radiotherapy.
  • Pregnant females
  • Previous abdominal surgery within the last 30 days.
  • Presence of concurrent abdominal wall infections.
  • Trauma Laparotomies
  • Large Bowel perforations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Incidence of Superficial Surgical site infectionsUpto 4 weeks post-operatively

Development of Superficial Surgical Site Infection as determined by the CDC guidelines.

Secondary Outcome Measures
NameTimeMethod
Length of Hospital StayUpto 4 weeks post-operatively

Number of in-hospital days (from time of admission to time of discharge)

Trial Locations

Locations (1)

Dr. Ruth K. M. Pfau Civil Hospital Karachi

🇵🇰

Karachi, Sindh, Pakistan

Dr. Ruth K. M. Pfau Civil Hospital Karachi
🇵🇰Karachi, Sindh, Pakistan
Omer Bin khalid, Asst. Prof
Contact
+92 321 2040064
dromerkhalid@gmail.com
Omer Bin Khalid, FCPS-II
Principal Investigator
Afeera Bashir, Undergrad.
Sub Investigator
Azzam Ali, Undergrad.
Sub Investigator
Bushra Saeed Khan, FCPS-I
Sub Investigator
Rabbiyya Ali, FCPS-II
Sub Investigator
Imrana Zulfikar, FCPS-II
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.